Family history: the neglected risk factor in disease prevention
Author: Simon E P Hauser
Published online: 4 October 2010
To the Editor: I read the article by Langlands and colleagues1 with some dismay, and a sinking heart. Their report is further evidence of the dangers of moving away from the basic skills of comprehensive history taking and performing a detailed physical examination. Interestingly, in the United States, the debate regarding performing a physical examination has come full circle, from virtually ignoring its importance to now telling us how vital it is and how to perform it.2 But it is the taking of a comprehensive history that, as one of my mentors told me, “is where the money is”, and a detailed family history is an integral part of this.
Eliciting a detailed family history is arguably more important for paediatric patients, who have a longer potential life span and hence have more to gain from this information. In my paediatric practice, for example, I see numerous overweight children, some of whom have a strong family history of hypercholesterolaemia, vascular disease or type 2 diabetes mellitus, which places them at considerable risk of cardiovascular disease in their adult years. A detailed family history may also “unmask” the genetic contribution to a child’s history of deafness or learning disability.
Time constraint is the main impediment to taking a comprehensive family history, but it is worth keeping in mind that it is time well spent and that, in the paediatric population, it may make a significant contribution to the long-term health of the child. With the impending advent of personalised genomic screening, there will be an even greater imperative to formalise the gathering of family history details.3,4
References
- Langlands AR, Prentice DA, Ravine D. A retrospective audit of family history records in short-stay medical admissions. Med J Aust 2010; 192: 682-684.
- Verghese A, Horwitz RI. In praise of the physical examination [editorial]. BMJ 2009; 339: b5448. 0_pgfId-2119859
- Edelman E, Eng C. A practical guide to interpretation and clinical application of personal genomic screening. BMJ 2009; 339: b4253. 0_CBBDCAAF
- Collins FS. The language of life: DNA and the revolution in personalized medicine. New York: Harper, 2010. 0_i1095405
When ‘Liver Enzymes’ Are Not Hepatic: Late-Onset Pompe Disease
Shauna Madigan, Georgina England, Wayne Rankin
Genomic Newborn Screening: Verdict From an Australian Citizens’ Jury
Emma Frost, Zornitza L. Stark, Kristen Nowak, Louise Healy, Sarah Norris, Stacy M. Carter
Genomic Testing Access for Hearing Loss Must Catch Up to the Evidence
Emma McGonigal, Andrew V. White, Valerie Sung, Karen Liddle, Lilian Downie, Emily Shepard
Population-Based Melanoma Screening Using Integrated Risk Scores in Australia: A Narrative Review to Determine Readiness
Courtney K. Wallingford, Chloe Mighton, Tamara Dawson, Anne Cust, H. Peter Soyer, Yvonne Bombard, Tatiane Yanes, Aideen McInerney-Leo
Genomic Newborn Screening: Commodity or Public Good?
Christopher Gyngell, Sebastian Lunke, Danya Vears, Zornitza L. Stark
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, John D Blakey, Shyamali C Dharmage, Paul Foster, Peter G Gibson, Adam Jaffe, Alan James, Christine R Jenkins, Sundram Sivamalai, Peter D Sly, Guy B Marks, Vanessa M McDonald, Judy Wetttenhall